Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue SUPPL. 1, 2008, Pages

  Breitbach, Katrin ^a,b   Köhler, Jens ^a   Steinmetz, Ivo ^a,b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Attenuated mutant; Burkholderia pseudomallei; Live vaccine; Melioidosis; purM; purN

Indexed keywords

BACTERIAL PROTEIN; LIVE VACCINE; PROTEIN HISF; PROTEIN PABB; PROTEIN PURM; PROTEIN PURN; PURINE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; KNOCKOUT GENE; LIFE CYCLE; MELIOIDOSIS; MOUSE; NONHUMAN; PROTECTION; TRANSPOSON; VACCINATION; WILD TYPE;

ANIMALS; BACTERIAL VACCINES; BURKHOLDERIA PSEUDOMALLEI; CELL CYCLE; DNA TRANSPOSABLE ELEMENTS; GENES, BACTERIAL; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MUTATION; VACCINES, ATTENUATED;

BURKHOLDERIA PSEUDOMALLEI; MUS; NEGIBACTERIA;

EID: 58049177333     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(08)70022-1     Document Type: Article

References (24)

1. White N.J. Melioidosis. Lancet 361 (2003) 1715-1722
2. Dance D.A. Melioidosis. Curr Opin Infect Dis 15 (2002) 127-132
3. Leelarasamee A., and Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 11 (1989) 413-425
4. Chaowagul W., White N.J., Dance D.A., Wattanagoon Y., Naigowit P., Davis T.M., et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 159 (1989) 890-899
5. Currie B.J., Fisher D.A., Howard D.M., Burrow J.N., Lo D., Selva-Nayagam S., et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31 (2000) 981-986
6. Atkins T., Prior R.G., Mack K., Russell P., Nelson M., Oyston P.C., et al. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 70 (2002) 5290-5294
7. Chen Y.S., Hsiao Y.S., Lin H.H., Yen C.M., Chen S.C., and Chen Y.L. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 24 (2006) 750-758
8. Elvin S.J., Healey G.D., Westwood A., Knight S.C., Eyles J.E., and Williamson E.D. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect Immun 74 (2006) 1706-1711
9. Nelson M., Prior J.L., Lever M.S., Jones H.E., Atkins T.P., and Titball R.W. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 53 (2004) 1177-1182
10. Stevens M.P., Haque A., Atkins T., Hill J., Wood M.W., Easton A., et al. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150 (2004) 2669-2676
11. Wongratanacheewin S., Kespichayawattana W., Intachote P., Pichyangkul S., Sermswan R.W., Krieg A.M., et al. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei. Infect Immun 72 (2004) 4494-4502
12. Haque A., Chu K., Easton A., Stevens M.P., Galyov E.E., Atkins T., et al. A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J Infect Dis 194 (2006) 1241-1248
13. Pilatz S., Breitbach K., Hein N., Fehlhaber B., Schulze J., Brenneke B., et al. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun 74 (2006) 3576-3586
14. Wuthiekanun V., Smith M.D., Dance D.A., Walsh A.L., Pitt T.L., and White N.J. Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol 45 (1996) 408-412
15. Ashdown L.R. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 11 (1979) 293-297
16. Sambandamurthy V.K., and Jacobs Jr W.R. Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect 7 (2005) 955-961
17. Levine H.B., and Maurer R.L. Immunization with an induced avirulent auxotrophic mutant of Pseudomonas pseudomallei. J Immunol 81 (1958) 433-438
18. Pechous R., Celli J., Penoske R., Hayes S.F., Frank D.W., and Zahrt T.C. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun 74 (2006) 4452-4461
19. Quarry J.E., Isherwood K.E., Michell S.L., Diaper H., Titball R.W., and Oyston P.C. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine 25 (2007) 2011-2018
20. Barnes J.L., and Ketheesan N. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Immunol Cell Biol 85 (2007) 551-557
21. Healey G.D., Elvin S.J., Morton M., and Williamson E.D. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 73 (2005) 5945-5951
22. Liu B., Koo G.C., Yap E.H., Chua K.L., and Gan Y.H. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70 (2002) 504-511
23. Ulett G.C., Labrooy J.T., Currie B.J., Barnes J.L., and Ketheesan N. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 7 (2005) 1263-1275
24. Chen Y.S., Hsiao Y.S., Lin H.H., Liu Y., and Chen Y.L. CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice. Infect Immun 74 (2006) 1699-1705